Pharmacokinetic evaluation of palifermin for mucosal protection from chemotherapy and radiation
出版年份 2011 全文链接
标题
Pharmacokinetic evaluation of palifermin for mucosal protection from chemotherapy and radiation
作者
关键词
-
出版物
Expert Opinion on Drug Metabolism & Toxicology
Volume 7, Issue 4, Pages 505-515
出版商
Informa Healthcare
发表日期
2011-03-19
DOI
10.1517/17425255.2011.566556
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Single-Dose Palifermin Prevents Severe Oral Mucositis During Multicycle Chemotherapy in Patients With Cancer
- (2013) Saroj Vadhan-Raj ANNALS OF INTERNAL MEDICINE
- A 3-day short course of palifermin before HDT reduces toxicity and need for supportive care after autologous blood stem-cell transplantation in patients with multiple myeloma
- (2010) G. Kobbe et al. ANNALS OF ONCOLOGY
- Effect of recombinant human keratinocyte growth factor (Δ23rHuKGF, Palifermin) on inflammatory and immune changes in mouse tongue during fractionated irradiation
- (2010) Jana Jaal et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Oral cryotherapy reduces mucositis and improves nutrition - a randomised controlled trial
- (2010) Anncarin Svanberg et al. JOURNAL OF CLINICAL NURSING
- Effect of tumour-cell-derived or recombinant keratinocyte growth factor (KGF) on proliferation and radioresponse of human epithelial tumour cells (HNSCC) and normal keratinocytes in vitro
- (2010) Andrea Hille et al. RADIATION AND ENVIRONMENTAL BIOPHYSICS
- Pro-inflammatory cytokines play a key role in the development of radiotherapy-induced gastrointestinal mucositis
- (2010) Zhi Ong et al. Radiation Oncology
- Palifermin, a recombinant human keratinocyte growth factor, triggers reactivation of anogenital human papillomavirus infection in a HIV-positive patient with diffuse large cell B-cell non-Hodgkin lymphoma
- (2009) T Schroeder et al. BONE MARROW TRANSPLANTATION
- Mucositis: The impact, biology and therapeutic opportunities of oral mucositis
- (2009) Stephen T. Sonis ORAL ONCOLOGY
- Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis
- (2008) E. Schmidt et al. ANNALS OF ONCOLOGY
- Long-Term follow-up of a Phase I/II Randomized, Placebo-Controlled Trial of Palifermin to Prevent Graft-versus-Host Disease (GVHD) after Related Donor Allogeneic Hematopoietic Cell Transplantation (HCT)
- (2008) John E. Levine et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients
- (2008) S Langner et al. BONE MARROW TRANSPLANTATION
- Palifermin dose should be adjusted to different therapy regimens
- (2008) M P M Verhagen et al. BONE MARROW TRANSPLANTATION
- Palifermin Reduces Severe Oral Mucositis in Subjects with Locally Advanced Head and Neck Cancer Undergoing Chemoradiotherapy
- (2008) Q. Le et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group
- (2008) Nicole Blijlevens et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Palifermin and Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma
- (2008) David M. Brizel et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started